Clozapine Reduces All-Cause Mortality
Author:
- 1 October 2017
- journal article
- editorial
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 174 (10) , 920-921
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Mortality and Self-Harm in Association With Clozapine in Treatment-Resistant SchizophreniaAmerican Journal of Psychiatry, 2017
- Real-World Effectiveness of Antipsychotic Treatments in a Nationwide Cohort of 29 823 Patients With SchizophreniaJAMA Psychiatry, 2017
- Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and TerminologyAmerican Journal of Psychiatry, 2017
- The Role of Clozapine in Treatment-Resistant SchizophreniaJAMA Psychiatry, 2016
- Efficacy, Acceptability, and Tolerability of Antipsychotics in Treatment-Resistant SchizophreniaJAMA Psychiatry, 2016
- Comparative Effectiveness of Clozapine and Standard Antipsychotic Treatment in Adults With SchizophreniaAmerican Journal of Psychiatry, 2016
- Termination of Clozapine Treatment Due to Medical ReasonsThe Journal of Clinical Psychiatry, 2013
- Clozapine Treatment for Suicidality in SchizophreniaInternational Suicide Prevention Trial (InterSePT)Archives of General Psychiatry, 2003
- Clozapine for the Treatment-Resistant SchizophrenicArchives of General Psychiatry, 1988